SCHEMBL31465843

SCHEMBL31465843

Cc1cc(C2CCN(CCN3CCOCC3)CC2)nn1-c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ SIGMAR1 Q99720 14/20 0.47
▸ HTR2B P41595 1/20 0.47
▸ SMN1; SMN2 Q16637 2/20 0.46
▸ L3MBTL1 Q9Y468 1/20 0.46
▸ NPC1 O15118 1/20 0.44
▸ LMNA P02545 1/20 0.44
▸ TP53 P04637 1/20 0.44
▸ PKM P14618 1/20 0.44
▸ RAB9A P51151 1/20 0.44
▸ TMEM97 Q5BJF2 1/20 0.43
▸ KCNH2 Q12809 1/20 0.43
▸ KDM4E B2RXH2 2/20 0.42
▸ ALDH1A1 P00352 2/20 0.42
▸ HPGD P15428 1/20 0.42
▸ MEN1 O00255 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ HSD17B10 Q99714 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31466526 0.90 DRD2 (0.40) SIGMAR1HTR2BSMN1; SMN2L3MBTL1NPC1
SCHEMBL31465869 0.88 SIGMAR1 (0.52) SIGMAR1HTR2BKCNH2
SCHEMBL31466156 0.87 HTR4 (0.42) SMN1; SMN2L3MBTL1NPC1LMNATP53
SCHEMBL31466615 0.86 SIGMAR1 (0.45) SIGMAR1HTR2BSMN1; SMN2KCNH2KDM4E
SCHEMBL31466107 0.85 SIGMAR1 (0.44) SIGMAR1HTR2BKCNH2KDM4E
SCHEMBL31465980 0.82 SIGMAR1 (0.44) SIGMAR1HTR2BKCNH2ALDH1A1MEN1
SCHEMBL31465985 0.82 ABL1 (0.46) SIGMAR1HTR2BKCNH2
SCHEMBL14686768 0.80 PRCP (0.57) SIGMAR1L3MBTL1MEN1KMT2A
SCHEMBL31466386 0.76 SIGMAR1 (0.78) SIGMAR1HTR2BKCNH2
SCHEMBL31466032 0.75 NPC1 (0.51) SIGMAR1SMN1; SMN2NPC1LMNATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025049419-A1 PYRAZOLYL COMPOUNDS AS EMOPAMIL BINDING PROTEIN INHIBITORS GENZYME CORPORATION (US) 2025-03-06 — — WO disclosed
Send feedback